Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery

Journal of Gene Medicine

Volumn 15, Issue 8-9, 2013, Pages 291-305

  Lei, Yang ^a   Wang, Jing ^a   Xie, Cao ^a   Wagner, Ernst ^a   Lu, Weiyue ^a   Li, Ying ^a   Wei, Xiaoli ^a   Dong, Jibin ^a   Liu, Min ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

C(RGDyK); Gene delivery; Glutathione sensitive; Intracranial glioblastoma targeted

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; DISULFIDE; GLUTATHIONE; MACROGOL; MACROGOL 2000; MACROGOL 25000; PHOSPHATE BUFFERED SALINE; POLYETHYLENEIMINE; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOTOXICITY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENE VECTOR; GLIOBLASTOMA; IN VITRO GENE TRANSFER; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REPORTER GENE; ZETA POTENTIAL;

C(RGDYK); GENE DELIVERY; GLUTATHIONE-SENSITIVE; INTRACRANIAL GLIOBLASTOMA TARGETED;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DISULFIDES; GENES, REPORTER; GENETIC THERAPY; GLIOBLASTOMA; GLUTATHIONE; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; OXIDATION-REDUCTION; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; TRANSFECTION;

EID: 84885097111     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2726     Document Type: Article

References (48)

1. Boussif O, Lezoualch F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo. Proc Natl Acad Sci U S A 1995; 92: 7297-7301.
2. Fischer D, Bieber T, Li Y, et al. A novel nonviral vector for DNA delivery based on low molecular weight, branched polyethylenimne: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999; 16: 1273-1279.
3. Erbacher P, Roche AC, Monsigny M, et al. The reduction of the positive charges of polylysine by partial gluconoylation increases the transfection efficiency of polylysine/DNA complexes. Biochim Biophys Acta 1997; 1324: 27-36.
4. Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 2005; 10: 1451-1458.
5. Goren D, Horowitz AT, Zalipsky S, et al. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. Br J Cancer 1996; 74: 1749-1756.
6. Van Vlerken LE, Vyas TK, Amiji MM. Poly(ethyleneglycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm Res 2007; 24: 1405-1414.
7. Ogris M, Brunner S, Schuller S, et al. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595-605.
8. Verbaan FJ, Oussoren C, Snel CJ, et al. Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice. J Gene Med 2004; 6: 64-75.
9. Sonawane ND, Szoka FJ, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003; 278: 44826-44831.
10. Harvie P, Wong FM, Bally MB. Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles. J Pharm Sci 2000; 89: 652-663.
11. Song LY, Ahkong QF, Rong Q, et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim Biophys Acta 2002; 1558: 1-13.
12. Liu J, Jiang X, Xu L, et al. Novel reduction-responsive cross-linked polyethylenimine derivatives by click chemistry for nonviral gene delivery. Bioconjugate Chem 2010; 21: 1827-1835.
13. Meyer M, Wagner E. pH-responsive shielding of non-viral gene vectors. Expert Opin Drug Deliv 2006; 3: 563-571.
14. Zhang GY, Liu J, Yang QZ, et al. Disulfide-containing brushed polyethylenimine derivative synthesized by click chemistry for nonviral gene delivery. Bioconjugate Chem 2012; 23: 1290-1299.
15. Walker GF, Fella C, Pelisek J, et al. Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol Ther 2005; 11: 418-425.
16. Kakizawa Y, Harada A, Kataoka K. Environment-sensitive stabilization of core-shell structured polyion complex micelle by reversible cross-linking of the core through disulfide bond. J Am Chem Soc 1999; 121: 11247-11248.
17. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30: 1191-1212.
18. Saito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Delivery Rev 2003; 55: 199-215.
19. Wang Y, Chen P, Shen J. The development and characterization of a glutathione-sensitive cross-linked polyethylenimine gene vector. Biomaterials 2006; 27: 5292-5298.
20. Park K, Lee MY, Kim KS, et al. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneiminee-hyaluronic acid conjugate. Biomaterials 2010; 31: 5258-5265.
21. Zeng X, Sun YX, Qu W, et al. Biotinylated transferrin/avidin/biotinylated disulfide containing PEI bioconjugates mediated p53 gene delivery system for tumor targeted transfection. Biomaterials 2010; 31: 4771-4780.
22. Son S, Singha K, Kim WJ. Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier. Biomaterials 2010; 31: 6344-6354.
23. Lin C, Zhong Z, Lok MC, et al. Linear poly(amido amine)s with secondary and tertiary amino groups and variable amounts of disulfide linkages: synthesis and in vitro gene transfer properties. J Control Release 2006; 116: 130-137.
24. Choi S, Lee KD. Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. J Control Release 2008; 131: 70-76.
25. Nounou MI, Emmanouil K, Chung S, et al. Novel reducible linear L-lysine-modified copolymers as efficient nonviral vectors. J Control Release 2010; 143: 326-334.
26. Zhang H, Vinogradov SV. Short biodegradable polyamines for gene delivery and transfection of brain capillary endothelial cells. J Control Release 2010; 143: 359-366.
27. Manickam DS, Li J, Putt DA, et al. Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors. J Control Release 2010; 141: 77-84.
28. Manickam DS, Hirata A, Putt DA, et al. Overexpression of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-responsive delivery vectors. Biomaterials 2008; 29: 2680-2688.
29. Kwok KY, McKenzie DL, Evers DL, et al. Formulation of highly soluble poly(ethylene glycol)-peptide DNA condensates. J Pharm Sci 1999; 88: 996-1003.
30. Sun W, Davis PB. Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism. J Control Release 2010; 146: 118-127.
31. Takae S, Miyata K, Oba M, et al. PEG-detachable polyplex micelles based on disulfide-linked block catiomers as bioresponsive nonviral gene vectors. J Am Chem Soc 2008; 130: 6001-6009.
32. Schottelius M, Laufer B, Kessler H, et al. Ligands for mapping alphavbeta3-integrin expression in vivo. Acc Chem Res 2009; 42: 969-980.
33. Erbacher P, Remy JS, Behr JP. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther 1999; 6: 138-145.
34. Schiffelers RM, Ansari A, Xu J, et al. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res 2004; 32: e149.
35. Hoffmann J, Fichtner I, Lemm M, et al. Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases. Neuro Oncol 2009; 11: 158-166.
36. Biris N, Abatzis M, Mitsios JV, et al. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3). Eur J Biochem 2003; 270: 3760-3767.
37. Martin I, Dohmen C, Mas-Moruno C, et al. Solid-phase-assisted synthesis of targeting peptide-PEG-oligo(ethane amino)amides for receptor-mediated gene delivery. Org Biomol Chem 2012; 10: 3258-3268.
38. Thorpe PE, Ross WC. The preparation and cytotoxic properties of antibody-toxin conjugates. Immunol Rev 1982; 62: 119-158.
39. Kumar A, Malhotra S. A simple method for introducing -SH group at 5'OH terminus of oligonucleotide. Nucleosides Nucleotides 1992; 11: 1003-1007.
40. Plank C, Mechtler K, Szoka FJ, et al. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 7: 1437-1446.
41. Merkel OM, Germershaus O, Wada CK, et al. Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine). Bioconjugate Chem 2009; 20: 1270-1280.
42. Zhan C, Qian J, Feng L, et al. Cyclic RGD-poly(ethylene glycol)-polyethyleneimine is more suitable for glioblastoma targeting gene transfer in vivo. J Drug Target 2011; 19: 573-581.
43. Mickler FM, Vachutinsky Y, Oba M, et al. Effect of integrin targeting and PEG shielding on polyplex micelle internalization studied by live-cell imaging. J Control Release 2011; 156: 364-373.
44. Nie Y, Schaffert D, Rödl W, et al. Dual-targeted polyplexes: one step towards a synthetic virus for cancer gene therapy. J Control Release 2011; 152: 127-134.
45. Seong JH, Lee KM, Kim ST, et al. Polyethylenimine-based antisense oligodeoxynucleotides of IL-4 suppress the production of IL-4 in a murine model of airway inflammation. J Gene Med 2006; 8: 314-323.
46. Rudolph C, Lausier J, Naundorf S, et al. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J Gene Med 2000; 2: 269-278.
47. Jiang L, Qian F, He X, et al. Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice. J Gene Med 2007; 9: 253-264.
48. Xiong MP, Forrest ML, Ton G, et al. Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection effciency for gene delivery. Biomaterials 2007; 28: 4889-4900.